Guangji Pharmaceutical: Legal Opinion Witnessing the 2024 Second Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Guangji Pharmaceutical: 2024 Semi-Annual Financial Report
Guangji Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Hubei Guangji Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Announcement on Resignation of Independent Director and Election of Independent Director
Hubei Guangji Pharmaceutical: Opinion of the 10th board of directors' nomination committee on the qualification review of independent director candidates.
Hubei Guangji Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Legal Opinion on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd. by Beijing Jing Shi (Wuhan) Law Firm
Hubei Guangji Pharmaceutical: Notice to creditors regarding the reduction of registered capital by repurchasing and canceling restricted stocks.
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Beijing Jingshi (Wuhan) Law Firm's witness legal opinion on the 2023 Annual General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Hubei Guangji Pharmaceutical: Announcement on the progress of plans to participate in bankruptcy and restructuring investments
Hubei Guangji Pharmaceutical: Internal Control Self-Assessment Report
Hubei Guangji Pharmaceutical: 2023 Annual Financial Report
Hubei Guangji Pharmaceutical: Announcement on preparation for impairment of assets accrued in 2023
Hubei Guangji Pharmaceutical: Notice on Obtaining a Notice of Approval for Supplemental Application for Pantoprazole Sodium Enteric Tablets
Hubei Guangji Pharmaceutical: Notice of Annual General Meeting of Shareholders
Hubei Guangji Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2023
No Data